Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Northwest Prostate Institute (NPI) was a specialized clinical and research center located at Northwest Hospital in Seattle, Washington, dedicated to the advanced treatment of prostate cancer. Founded and led by Dr. Haakon Ragde, a pioneer in ultrasound-guided brachytherapy, the institute was globally recognized for its work in developing and validating radioactive seed implantation techniques. NPI's landmark clinical studies, including long-term follow-up data published in major oncology journals, demonstrated that brachytherapy achieved cure rates comparable to radical surgery with significantly lower morbidity. The institute played a pivotal role in establishing minimally invasive radiation therapy as a standard of care for localized prostate cancer before its parent hospital was integrated into the UW Medicine system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Northwest Prostate Institute.